Review Article

An examination of natural and synthetic tyrosinase inhibitors

Volume: 3 Number: 3 December 31, 2024
EN

An examination of natural and synthetic tyrosinase inhibitors

Abstract

The enzyme responsible for this process is known as tyrosinase, which is sometimes referred to as polyphenol oxidase, monophenol oxidase, phenolase, or catecholase. It is present in humans, plants, microbes, and fungi. Melanin pigments, found in both plants and animals, require this enzyme as an essential component. Tyrosinase is present in animal creatures, particularly in the pigments of the skin, hair, and eyes. Tyrosinase can cause darkening in foods that is unrelated to their inherent color. Beverages such as fruit juice and wine may experience a decline in appearance and flavor, as well as the occurrence of turbidity and precipitation. The unwanted phenomenon of browning in fruits and vegetables, which is frequently caused by enzymatic processes, needs to be avoided. Tyrosinase enzyme inhibitors are employed to hinder the catalytic oxidations that lead to browning by the tyrosinase enzyme. Currently, these basic ingredients are commonly found in skin whitening solutions, particularly in the field of cosmetics. In addition, tyrosinase inhibitors have practical applications in the treatment of skin problems associated with melanin pigmentation. Furthermore, tyrosinase inhibitors competitively and reversibly hinder the activity of human melanocyte tyrosinase, hence impeding the production of melanin. Numerous substances possess the ability to hinder the activity of the enzyme tyrosinase. Ongoing studies are being conducted on several derivatized compounds to increase inhibition. This article explores the inhibitory effects of many compounds, including kojic acid, azelaic acid, flavonoids, arbutin-deoxyarbutin, curcumin and its derivatives, and copper chelators, on the enzyme tyrosinase.

Keywords

References

  1. Chang T-S. An Updated Review of Tyrosinase Inhibitors. Int J Mol Sci (2009);10:2440–75. https://doi.org/10.3390/ijms10062440.
  2. Zou C, Huang W, Zhao G, Wan X, Hu X, Jin Y, et al. Determination of the Bridging Ligand in the Active Site of Tyrosinase. Molecules (2017);22:1836. https://doi.org/10.3390/molecules22111836.
  3. Loizzo MR, Tundis R, Menichini F. Natural and Synthetic Tyrosinase Inhibitors as Antibrowning Agents: An Update. Compr Rev Food Sci Food Saf (2012);11:378–98. https://doi.org/10.1111/j.1541-4337.2012.00191.x.
  4. Zolghadri S, Bahrami A, Hassan Khan MT, Munoz-Munoz J, Garcia-Molina F, Garcia-Canovas F, et al. A comprehensive review on tyrosinase inhibitors. J Enzyme Inhib Med Chem (2019);34:279–309. https://doi.org/10.1080/14756366.2018.1545767.
  5. Kim Y-J, Uyama H. Tyrosinase inhibitors from natural and synthetic sources: structure, inhibition mechanism and perspective for the future. Cell Mol Life Sci (2005);62:1707–23. https://doi.org/10.1007/s00018-005-5054-y.
  6. Baurin N, Arnoult E, Scior T, Do QT, Bernard P. Preliminary screening of some tropical plants for anti-tyrosinase activity. J Ethnopharmacol. (2002);82(2-3):155-8. doi: 10.1016/s0378-8741(02)00174-5. PMID: 12241990.
  7. Puspaningtyas AR. Evaluation of the effect of red guava (Psidium guajava) fruit extract on tyrosinase (EC 1.14.18.1) activity by spectrophotometry. Int Curr Pharm J (2012);1:92–7. https://doi.org/10.3329/icpj.v1i5.10280.
  8. Hasegawa T. Tyrosinase-Expressing Neuronal Cell Line as In Vitro Model of Parkinson’s Disease. Int J Mol Sci (2010);11:1082–9. https://doi.org/10.3390/ijms11031082.

Details

Primary Language

English

Subjects

Pharmacology and Pharmaceutical Sciences (Other)

Journal Section

Review Article

Publication Date

December 31, 2024

Submission Date

June 10, 2024

Acceptance Date

November 21, 2024

Published in Issue

Year 2024 Volume: 3 Number: 3

APA
Demirdiş, G. (2024). An examination of natural and synthetic tyrosinase inhibitors. European Journal of Life Sciences, 3(3), 114-126. https://doi.org/10.55971/EJLS.1498811
AMA
1.Demirdiş G. An examination of natural and synthetic tyrosinase inhibitors. Eur J Life Sci. 2024;3(3):114-126. doi:10.55971/EJLS.1498811
Chicago
Demirdiş, Gizem. 2024. “An Examination of Natural and Synthetic Tyrosinase Inhibitors”. European Journal of Life Sciences 3 (3): 114-26. https://doi.org/10.55971/EJLS.1498811.
EndNote
Demirdiş G (December 1, 2024) An examination of natural and synthetic tyrosinase inhibitors. European Journal of Life Sciences 3 3 114–126.
IEEE
[1]G. Demirdiş, “An examination of natural and synthetic tyrosinase inhibitors”, Eur J Life Sci, vol. 3, no. 3, pp. 114–126, Dec. 2024, doi: 10.55971/EJLS.1498811.
ISNAD
Demirdiş, Gizem. “An Examination of Natural and Synthetic Tyrosinase Inhibitors”. European Journal of Life Sciences 3/3 (December 1, 2024): 114-126. https://doi.org/10.55971/EJLS.1498811.
JAMA
1.Demirdiş G. An examination of natural and synthetic tyrosinase inhibitors. Eur J Life Sci. 2024;3:114–126.
MLA
Demirdiş, Gizem. “An Examination of Natural and Synthetic Tyrosinase Inhibitors”. European Journal of Life Sciences, vol. 3, no. 3, Dec. 2024, pp. 114-26, doi:10.55971/EJLS.1498811.
Vancouver
1.Gizem Demirdiş. An examination of natural and synthetic tyrosinase inhibitors. Eur J Life Sci. 2024 Dec. 1;3(3):114-26. doi:10.55971/EJLS.1498811

Announcement

Dear Readers, Authors, and Reviewers,

An inconsistency has been identified in the automatically generated editorial board information due to a technical issue in the infrastructure that enables the electronic management of our journal. As a result of this technical problem, the current editorial board information can be accessed on DergiPark at https://dergipark.org.tr/en/pub/ejls/board.

However, the editorial board and reviewer information for a published issue are included in the PDF file of the relevant issue. Therefore, the accurate and authoritative information should be accessed through the PDF of the respective issue.

For your information.

**Click here for an important announcement regarding the Editorial Board.**